Interleukin-23 Subunit p19

Name
Interleukin-23 Subunit p19
Accession Number
DBCAT005547
Description

Not Available

Drugs
DrugDrug Description
GuselkumabA monoclonal antibody used to treat moderate to severe plaque psoriasis.
TildrakizumabAn interleukin-23 antagonist used to treat moderate to severe plaque psoriasis.
RisankizumabAn interleukin-23 antagonist used to treat plaque psoriasis, psoriatic arthritis, and Crohn's disease in adults.
Drugs & Drug Targets
DrugTargetType
GuselkumabInterleukin-23 subunit alphatarget
TildrakizumabInterleukin-23target
TildrakizumabCytochrome P450 4A11enzyme
RisankizumabInterleukin-23target